Literature DB >> 23692290

Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia.

Thomas Prebet1,2, Nadine Carbuccia3, Hana Raslova4, Rémi Favier4, Jerome Rey2, Christine Arnoulet5, Norbert Vey1,2, William Vainchenker4, Daniel Birnbaum3, Marie-Joelle Mozziconacci3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23692290     DOI： 10.1111/ejh.12147

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   3.674


× No keyword cloud information.
  7 in total

1.  Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.

Authors:  I Antony-Debré; N Duployez; M Bucci; S Geffroy; J-B Micol; A Renneville; N Boissel; N Dhédin; D Réa; B Nelken; C Berthon; T Leblanc; M-J Mozziconacci; R Favier; P G Heller; O Abdel-Wahab; H Raslova; V Latger-Cannard; C Preudhomme
Journal:  Leukemia       Date:  2015-08-28       Impact factor: 11.528

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  Myeloid neoplasms with germ line RUNX1 mutation.

Authors:  Yoshihiro Hayashi; Yuka Harada; Gang Huang; Hironori Harada
Journal:  Int J Hematol       Date:  2017-05-22       Impact factor: 2.490

Review 4.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 5.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 6.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

7.  Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.

Authors:  Vladimir T Manchev; Hind Bouzid; Iléana Antony-Debré; Betty Leite; Guillaume Meurice; Nathalie Droin; Thomas Prebet; Régis T Costello; William Vainchenker; Isabelle Plo; M'boyba Diop; Elizabeth Macintyre; Vahid Asnafi; Rémi Favier; Véronique Baccini; Hana Raslova
Journal:  J Cell Mol Med       Date:  2016-12-20       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.